首頁 > 市場調查報告書 > 食物/飲料

保健食品

市場調查報告書

商品編碼

1604563

骨化二醇補充品市場：未來預測（2025-2030）

Calcifediol Supplements Market - Forecasts from 2025 to 2030

出版日期: 2024年11月07日 | 出版商:

Knowledge Sourcing Intelligence | 英文 123 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

骨化二醇補充品市場預計將以 9.21% 的複合年成長率成長，市場規模從 2025 年的 14.094 億美元增至 2030 年的 21.893 億美元。

骨化二醇是血液中維生素 D 的活性形式，也稱為 25-羥基維生素 D3。從陽光或食物中攝取的維生素 D3 在肝臟中被羥基化並產生。用於測量體內維生素 D 水平。

骨化二醇補充品是一種更先進、更強大的維生素 D補充品。臨床證明，與其他方法相比，提高維生素 D 水平的速度和效率提高 3 倍。骨化二醇一水化合物（25-羥基維生素 D3）是一種維生素 D3 類似物，透過使用膽鈣化醇 25-羥化酶將維生素 D3（膽鈣化醇）羥基化而獲得。

全球維生素 D 缺乏症日益嚴重和人口老化正在推動維生素 D補充品市場的成長。骨化二醇比其他維生素 D補充品吸收得更快，可使體內維生素 D 水平增加三倍，從而導致需求增加。此外，其在治療次發性副甲狀腺機能亢進、低血鈣和預防骨質疏鬆症的應用將導致骨化二醇補充品市場的成長。

骨化二醇補充品市場的促進因素

維生素 D 缺乏症的加劇推動骨化二醇補充品市場成長

全球維生素 D 缺乏症患者的數量正在增加。與此同時，全球老年人口也不斷增加。這些因素創造了對維生素 D補充品的需求。骨化二醇是比其他維生素 D補充品更好的替代品。它為維生素 D 缺乏症提供了有效的解決方案，並且比傳統維生素 D3補充品更快、更有效地提高維生素 D 水平。

美國國家生物技術資訊中心的一項研究，維生素 D 缺乏症的盛行率很高，76.6% 的參與者血清 25-羥基維生素 D 缺乏症低於 75 nmol/l。全球整體約 30-45% 的人（即約 10 億人）缺乏維生素 D。

骨化二醇補充品市場的地理前景

預測期內，北美將成為骨化二醇補充品的最大市場

從地區來看，全球市場分為亞太地區、北美、南美、歐洲和中東/非洲。在預測期內，北美佔據骨化二醇補充品最大的市場佔有率。

北美的老年人口正在增加。根據美國人口普查局的一項計劃，美國約有 7,700 萬人年齡在 65 歲及以上。加拿大的人口也在老化。人口老化導致的維生素 D 缺乏，加上許多成年人的維生素 D 缺乏，將顯著增加北美地區對骨化二醇補充品的需求。儘管所有地區都面臨著維生素 D 缺乏的問題，但北美，尤其是美國，尋求營養食品的人數不斷增加，再加上健康領域的重大技術創新和進步，導致健康狀況得到改善。設施的滲透，預計骨化二醇補充品市場的成長最快。

為什麼要購買這份報告？

富有洞察力的分析：獲得涵蓋關鍵和新興地區的深入市場洞察，重點關注客戶細分、政府政策和社會經濟因素、消費者偏好、行業明智以及其他子區隔。
競爭格局：了解世界主要企業採取的策略策略，並了解透過正確的策略滲透市場的潛力。
市場促進因素和未來趨勢：探索動態因素和關鍵市場趨勢以及它們將如何塑造未來市場發展。
可行的建議：利用洞察力做出策略決策，以在動態環境中發現新的業務流和收益。
受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業有用且具有成本效益。

它有什麼用？

產業和市場考量、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開拓、競爭影響

調查範圍

2022年至2030年歷史資料與預測
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭定位、策略和市場佔有率分析
細分市場和區域評估，包括收益成長和預測國家
公司概況（尤其是關鍵發展等）

骨化二醇補充品市場細分與分析如下：

按類型

即時釋骨化二醇
緩釋骨化二醇

按用途

維生素D缺乏症
骨質疏鬆症
次發性副甲狀腺機能亢進
其他

按地區

北美洲
美國
加拿大
墨西哥
南美洲
巴西
阿根廷
其他
歐洲
英國
德國
法國
義大利
其他
中東/非洲
沙烏地阿拉伯
以色列
其他
亞太地區
日本
中國
印度
韓國
印尼
泰國
其他

Calcifediol supplements are a more advanced and powerful type of vitamin D supplement. It has been clinically demonstrated to increase vitamin D levels three times quicker and more efficiently than other methods. Calcifediol monohydrate (25-Hydroxyvitamin D3) is a vitamin D3 analogue created by hydroxylation of vitamin D3 (cholecalciferol) using the enzyme cholecalciferol 25-hydroxylase.

The increasing Vitamin D deficiency worldwide and the aging population are driving the market growth for its supplements. Calcifediol is a better alternative than other forms of Vitamin D supplements as it is absorbed more quickly and increases Vitamin D levels by 3 times in the body, thus leading to an increase in its demand. Moreover, its usage in treating secondary hyperparathyroidism, managing hypocalcemia, and preventing osteoporosis would help in increasing the calcifediol supplements market growth.

Calcifediol supplement market drivers

Rising Vitamin D deficiency would drive the market growth for calcifediol supplements

Globally, there is an increase in the number of people with Vitamin D deficiency. At the same time, the number of geriatric populations is on the rise worldwide. These factors are creating demand for Vitamin D supplements. Calcifediol is a superior alternative to other vitamin D supplements. It offers an effective solution for addressing vitamin D deficiency, providing a faster and more efficient method to raise vitamin D levels than traditional vitamin D3 supplements.

As per a study done by the National Center of Biotechnology Information, there are 76.6% of participants had serum 25-hydroxyvitamin D deficiency below 75 nmol/l, showing a higher prevalence of deficiency of vitamin D. Globally, approximately 30-45% of people have vitamin D deficiency, making it around 1 billion people.

Calcifediol supplement market geographical outlook

North America would be the largest market shareholder for calcifediol supplements in the forecast period

Region-wise, the global market is segmented into Asia-Pacific, North America, South America, Europe, Middle East and Africa. North America would hold the largest market share for Calcifediol supplements in the forecast period.

North America is experiencing a demographic shift towards the older population. In the United States of America, there are around 77 million people aged above 65, according to the U.S. Census Bureau Project. In Canada, the aging population is increasing, too. Vitamin D deficiency in the aging population, coupled with deficiency in a great number of adults, would significantly increase the demand for calcifediol supplements in the North American region. Though all the regions are facing the issue of vitamin D deficiency, North America, particularly the United States of America, would have the highest growth in the calcifediol supplement market as there are increasing trends among people for dietary supplements and the prevalence of advanced healthcare infrastructure coupled with significant innovations and the advancement in the health sector.

Reasons for buying this report:-

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data & forecasts from 2022 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The calcifediol supplement market is segmented and analyzed as given below:

By Type

Immediate-release calcifediol
Extended-release calcifediol

By Application

Vitamin D Deficiency
Osteoporosis
Secondary hyperparathyroidism
Others

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
UK
Germany
France
Italy
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Key Findings
3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Supplier
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. The Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. CALCIFEDIOL SUPPLEMENTS MARKET BY TYPE

5.1. Introduction
5.2. Immediate-release calcifediol
5.3. Extended-release calcifediol

6. CALCIFEDIOL SUPPLEMENTS MARKET BY APPLICATION

6.1. Introduction
6.2. Vitamin D Deficiency
6.3. Osteoporosis
6.4. Secondary hyperparathyroidism
6.5. Others

7. CALCIFEDIOL SUPPLEMENTS MARKET BY GEOGRAPHY

7.1. Introduction
7.2. North America
- 7.2.1. United States
- 7.2.2. Canada
- 7.2.3. Mexico
7.3. South America
- 7.3.1. Brazil
- 7.3.2. Argentina
- 7.3.3. Others
7.4. Europe
- 7.4.1. UK
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Others
7.5. Middle East and Africa
- 7.5.1. Saudi Arabia
- 7.5.2. Israel
- 7.5.3. Others
7.6. Asia Pacific
- 7.6.1. Japan
- 7.6.2. China
- 7.6.3. India
- 7.6.4. South Korea
- 7.6.5. Indonesia
- 7.6.6. Thailand
- 7.6.7. Others